Diet quality, asthma and airway inflammation in school-aged children

M Rodrigues1, F de Castro Mendes2,3, I Paciência4,5

  • 1Faculty of Nutrition and Food Sciences, University of Porto, Porto, Portugal.

Insights

A healthier diet may reduce asthma risk in children. Improved diet quality was linked to lower airway inflammation and fewer asthma diagnoses in non-overweight/obese children.

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Epidemiology
  • Respiratory Medicine

Background:

  • Asthma prevalence is rising globally, especially in children.
  • Poor dietary quality is also a growing concern in pediatric populations.
  • Limited research exists on the impact of overall dietary patterns on childhood asthma.

Purpose of the Study:

  • To investigate the association between diet quality and asthma prevalence and airway inflammation in school-aged children.
  • To analyze these associations based on body mass index (BMI) categories.
  • To explore the relationship between the Healthy Eating Index (HEI)-2015 and respiratory health markers.

Main Methods:

  • Cross-sectional study of 660 children (aged 7-12 years).
  • Diet quality assessed using the HEI-2015, categorized into tertiles.
  • Asthma diagnosis, medication use, lung function, and exhaled nitric oxide (eNO) were measured; BMI categorized as non-overweight/obese or overweight/obese.

Main Results:

  • Among non-overweight/obese children, higher HEI-2015 scores (2nd tertile) were associated with significantly reduced odds of elevated eNO (OR 0.43), asthma diagnosis (OR 0.18), and asthma treatment (OR 0.12) compared to the lowest tertile.
  • These protective associations were observed in children with healthier dietary patterns.
  • No significant associations were found in the overweight/obese group (results not detailed in abstract).

Conclusions:

  • Higher diet quality is associated with lower airway inflammation and reduced asthma prevalence in non-overweight/obese school-aged children.
  • Dietary interventions may play a role in managing or preventing asthma in this demographic.
  • Further research is needed to confirm these findings and explore mechanisms in different BMI categories.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
462
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
375
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K